Literature DB >> 25502962

Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases.

James C Marsh1, Stewart Goldman, Ellis Ziel, Corey Bregman, Aidnag Diaz, Richard Byrne, Jason Fangusaro.   

Abstract

To assess frequency of neural stem cell compartment (NSC) involvement in adult and pediatric gliomas [World Health Organization (WHO) grades 1-4], and to assess whether NSC involvement at presentation impacts on survival, recurrence rates, and/or transformation from low grade (WHO grade 1-2) to high grade disease (WHO grades 3-4). Cranial MRIs for 154 pediatric and 223 adult glioma patients treated from 2000 to 2012 were reviewed. NSC involvement was documented. Tumors were stratified by age (adult vs. pediatric), histology, tumor grade, tumor location, and involvement of midline structures. Odds ratios (OR) for death were calculated based on NSC status at presentation. Rates of transformation and recurrence rates (ORR) were compared using Fisher's Exact Test. Time to recurrence (TTR) was calculated using student t test. Among recurrent and transformed tumors, we also assessed the rate of NSC involvement at time of recurrence or transformation. 74.8 % of tumors had NSC involvement. Higher rates of NSC involvement were seen among adult (p = .0001); high grade (p = .0001)); grade 2 versus grade 1 (p = .0001) and other grade 1 histologies (p = .0001) versus JPA (juvenile pilocytic astrocytoma) patients); grade 2-4 tumors (p = .0001); and supratentorial tumors (p < .0001). No transformation was noted among pediatric low grade tumors or adult grade 1 tumors. 22/119 (18.5 %) adult grade 2 tumors transformed. Rates of transformation were not impacted by NSC status (p = .47). ORR was 15.1 %, and was greater for NSC+ tumors at presentation (p = .05). 36/41 recurrences (87.8 %) involved NSC at time of recurrence. OR for death was 2.62 (1.16-5.9), p = .02 for NSC+ tumors at presentation. Adult and pediatric gliomas (all grades) frequently involve NSC at presentation, although rates are lower in pediatric JPA and all infratentorial tumors. NSC involvement at presentation increases OR death and reduces TTR for pediatric gliomas (all grades) and adult low grade gliomas, and shows a strong trend toward increased ORR.

Entities:  

Mesh:

Year:  2014        PMID: 25502962     DOI: 10.1007/s11060-014-1682-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

1.  Low-grade pure and mixed cerebral astrocytomas treated in the CT scan era.

Authors:  J P Bahary; J G Villemure; S Choi; R Leblanc; A Olivier; G Bertrand; L Souhami; D Tampieri; J Hazel
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

Review 2.  Current concepts in the evaluation and management of WHO grade II gliomas.

Authors:  Joseph M Piepmeier
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

3.  Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.

Authors:  Percy Lee; Wietse Eppinga; Frank Lagerwaard; Timothy Cloughesy; Benjamin Slotman; Phioanh L Nghiemphu; Pin-Chieh Wang; Patrick Kupelian; Nzhde Agazaryan; John Demarco; Michael T Selch; Michael Steinberg; Jung Julie Kang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-22       Impact factor: 7.038

4.  Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.

Authors:  K Lote; T Egeland; B Hager; B Stenwig; K Skullerud; J Berg-Johnsen; I Storm-Mathisen; H Hirschberg
Journal:  J Clin Oncol       Date:  1997-09       Impact factor: 44.544

5.  Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.

Authors:  Linda Chen; Hugo Guerrero-Cazares; Xiaobu Ye; Eric Ford; Todd McNutt; Lawrence Kleinberg; Michael Lim; Kaisorn Chaichana; Alfredo Quinones-Hinojosa; Kristin Redmond
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-03-26       Impact factor: 7.038

6.  Prognostic factors for survival in adult patients with cerebral low-grade glioma.

Authors:  Francesco Pignatti; Martin van den Bent; Desmond Curran; Channa Debruyne; Richard Sylvester; Patrick Therasse; Denes Afra; Philippe Cornu; Michel Bolla; Charles Vecht; Abul B M F Karim
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

7.  Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy.

Authors:  C A North; R B North; J A Epstein; S Piantadosi; M D Wharam
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

8.  Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma.

Authors:  Patrick Evers; Percy P Lee; John DeMarco; Nzhde Agazaryan; James W Sayre; Michael Selch; Frank Pajonk
Journal:  BMC Cancer       Date:  2010-07-21       Impact factor: 4.430

Review 9.  Brain cancer propagating cells: biology, genetics and targeted therapies.

Authors:  Costas G Hadjipanayis; Erwin G Van Meir
Journal:  Trends Mol Med       Date:  2009-11-02       Impact factor: 11.951

Review 10.  Recent trends in the radiotherapy of pediatric gliomas.

Authors:  N J Tarbell; J S Loeffler
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.